Cingulate Inc. (CING)
NASDAQ: CING · IEX Real-Time Price · USD
0.338
+0.003 (0.75%)
Jul 22, 2024, 10:19 AM EDT - Market open
Cingulate Employees
Cingulate had 13 employees as of December 31, 2023. The number of employees decreased by 2 or -13.33% compared to the previous year.
Employees
13
Change (1Y)
-2
Growth (1Y)
-13.33%
Revenue / Employee
n/a
Profits / Employee
-$1,730,964
Market Cap
3.50M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 13 | -2 | -13.33% |
Dec 31, 2022 | 15 | -1 | -6.25% |
Dec 31, 2021 | 16 | 4 | 33.33% |
Dec 31, 2020 | 12 | - | - |
Related Stocks
Company Name | Employees |
---|---|
ASLAN Pharmaceuticals | 35 |
FOXO Technologies | 29 |
Helius Medical Technologies | 22 |
Tenon Medical | 21 |
Catheter Precision | 14 |
Cyclacel Pharmaceuticals | 12 |
Virax Biolabs Group | 11 |
Altamira Therapeutics | 10 |
CING News
- 24 days ago - Cingulate Announces Exercise of Warrants for $1.86 Million Gross Proceeds - GlobeNewsWire
- 26 days ago - Cingulate and ADHD Expert Dr. Ann Childress, MD to Participate in Benzinga All Live Access Event - GlobeNewsWire
- 27 days ago - Cingulate Achieves Key Manufacturing Milestone in the Development of its ADHD Drug CTx-1301 in Preparation for FDA Marketing Clearance - GlobeNewsWire
- 2 months ago - Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update - GlobeNewsWire
- 2 months ago - Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured with Chairman and CEO Shane J. Schaffer on Benzinga All Live Access - GlobeNewsWire
- 3 months ago - Cingulate to Participate in Planet MicroCap Showcase: Vegas 2024 - GlobeNewsWire
- 4 months ago - Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update - GlobeNewsWire
- 4 months ago - Cingulate to Participate in Benzinga All Live Access Event - GlobeNewsWire